探索基于蒂奥芬的药作为神经退行性疾病的新兴治疗方法
Shivank Sharma1, Mukta Gupta1, Shivani Sharma1
1School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India.
Critical reviews in analytical chemistry
|September 8, 2025
概括
烯衍生物通过向蛋白质聚合和氧化应激等多种途径,显示出治疗神经退行性疾病 (NDD) 的前景. 需要进一步的研究来改善它们的临床使用.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经退行性疾病 (NDD) 代表着日益严重的全球健康危机,疾病修饰治疗有限.
- 目前的治疗方案主要是治疗症状,而不是治疗潜在原因,如蛋白质聚合,氧化应激和神经炎症.
- NDD的多因素性质需要新的治疗策略和化学支架.
研究的目的:
- 系统地审查蒂奥芬衍生物作为NDD的潜在治疗方法.
- 突出蒂奥芬支架在NDD治疗中的多功能性和治疗潜力.
- 探索结构-活性关系和用于NDD的烯基化合物的临床前进展.
主要方法:
- 对2006年至2024年间发现的烯衍生物的系统文献综述.
- 对化合物机制的分析,包括粉样β聚合调节,乙胆酶抑制和氧化应激缓解.
- 对结构-活性关系 (SAR) 研究,合成方法,分子对接和临床前评估的审查.
主要成果:
- 烯衍生物在调节关键的NDD病理方面表现出有效性,包括粉样β聚合和α-synuclein毒性.
- 化合物具有抑制乙胆酶和减轻氧化应激和神经炎症的潜力.
- 硫烯支架显示微到纳米分子活性,具有有利的特性,如结构形性和血脑屏障透性.
结论:
- 烯衍生物代表了一个有前途和多功能的化学平台,用于开发下一代NDD疗法.
- 它们的多重准能力和有利的物理化学特性比传统的异环化合物具有优势.
- 未来的研究应该集中在药物动力学优化,目标验证和转化研究上,以推进临床效用.
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Alzheimer's Disease: Treatment
827
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
827
Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
Parkinson's Disease: Treatment
995
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
995
Neurochemical Transmission: Sites of Drug Action
3.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.5K


